Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Jiajie Hou^{1

2

3

4}, He Zhang^{5

6}, Jun Liu⁷, Zhenjun Zhao⁵, Jianye Wang⁵, Zhike Lu⁷, Bian Hu⁸, Jiankui Zhou⁸, Zhicong Zhao⁵, Mingxuan Feng⁵, Haiyan Zhang^{9

10}, Bin Shen¹¹, Xingxu Huang⁸, Beicheng Sun¹², Mark J Smyth¹⁰, Chuan He^{13

14}, Qiang Xia¹⁵

Affiliations

¹ Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China. houjj@sysucc.org.cn.
² Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210093, China. houjj@sysucc.org.cn.
³ Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. houjj@sysucc.org.cn.
⁴ State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. houjj@sysucc.org.cn.
⁵ Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
⁶ Department of Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China.
⁷ Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, 60637, USA.
⁸ School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
⁹ State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
¹⁰ Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, 4006, Australia.
¹¹ Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing, 211166, China.
¹² Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210093, China.
¹³ Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, 60637, USA. chuanhe@uchicago.edu.
¹⁴ Howard Hughes Medical Institute, University of Chicago, Chicago, IL, 60637, USA. chuanhe@uchicago.edu.
¹⁵ Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China. xiaqiang@shsmu.edu.cn.

PMID: 32887624
PMCID: PMC7650264
DOI: 10.1186/s12943-020-01257-8

Published Erratum

Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Jiajie Hou et al. Mol Cancer. 2020.

. 2020 Sep 4;19(1):137.

doi: 10.1186/s12943-020-01257-8.

Authors

Affiliations

¹ Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China. houjj@sysucc.org.cn.
² Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210093, China. houjj@sysucc.org.cn.
³ Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. houjj@sysucc.org.cn.
⁴ State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. houjj@sysucc.org.cn.
⁵ Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
⁶ Department of Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China.
⁷ Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, 60637, USA.
⁸ School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
⁹ State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
¹⁰ Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, 4006, Australia.
¹¹ Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing, 211166, China.
¹² Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210093, China.
¹³ Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, 60637, USA. chuanhe@uchicago.edu.
¹⁴ Howard Hughes Medical Institute, University of Chicago, Chicago, IL, 60637, USA. chuanhe@uchicago.edu.
¹⁵ Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China. xiaqiang@shsmu.edu.cn.

PMID: 32887624
PMCID: PMC7650264
DOI: 10.1186/s12943-020-01257-8

Abstract

An amendment to this paper has been published and can be accessed via the original article.

PubMed Disclaimer

Erratum for

YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.
Hou J, Zhang H, Liu J, Zhao Z, Wang J, Lu Z, Hu B, Zhou J, Zhao Z, Feng M, Zhang H, Shen B, Huang X, Sun B, Smyth MJ, He C, Xia Q. Hou J, et al. Mol Cancer. 2019 Nov 18;18(1):163. doi: 10.1186/s12943-019-1082-3. Mol Cancer. 2019. PMID: 31735169 Free PMC article.

References

1. Hou J, Zhang H, Liu J, et al. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Mol Cancer. 2019;18:163. doi: 10.1186/s12943-019-1082-3. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Affiliations

Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Authors

Affiliations

Abstract

Erratum for

References

Publication types

LinkOut - more resources

Full Text Sources